Burjeel Holdings Launches Advanced Gynecology Institute to Offer Complex Care Solutions for Women

The institute at Burjeel Medical City in collaboration with IFEM Endo marks a significant milestone in advancing women’s healthcare in the region.

Abu Dhabi, United Arab Emirates, 23 May 2023: Burjeel Holdings (“Burjeel” or “the Group”), a leading ADX-listed Healthcare Services Provider in the UAE and MENA, today announced the launch of the Advanced Gynecology Institute, fostering the provision of complex care solutions for women’s healthcare in the region.
Located at Burjeel’s flagship 1.2 million square feet hospital, Burjeel Medical City, the Advanced Gynecology Institute is designed to offer timely, sophisticated, and multidisciplinary healthcare solutions to women of all ages. The launch of the institute comes just months after the hospital joined hands with the globally renowned Franco-European Multidisciplinary Institute of Endometriosis Academy (IFEM Endo).
The institute was inaugurated by H.E. Dr. Maitha Bint Salem Al Shamsi, Minister of State, UAE Government, during a ceremony held at Burjeel Medical City. The inaugural ceremony was also attended by Dr. Ghuwaya Al Neyadi, Non-Executive Director at Burjeel Holdings, H.E. Nora Al Mareikhi, Chairwoman of Hemmah, and Professor Dr. Sherine Farouk, Associate Provost of Academic Projects, Abu Dhabi University, along with senior management officials from Burjeel Holdings.
Three specialized clinics of the hospital – Gynecological Oncology, IFEM Endo Middle East Clinic, and Complex Gynecology Care – will come under the newly formed institute. It will offer advanced and comprehensive care including gynecological surgeries, minimally invasive procedures, and complex gynecology care for a wide range of conditions, including menorrhagia, fibroids, and benign ovarian masses. One of the key specialties of the institute is its cutting-edge offerings for endometriosis, which, according to the World Health Organization (WHO), affects roughly 10% of reproductive-age women and girls globally.
The expert team will also be involved in clinical research and training, which will broaden the horizons of the region’s complex gynecology and gynecologic cancer care.
Professor Horace Roman, a renowned endometriosis surgeon and founding member of IFEM Endo, will lead the institute, supported by a team of highly qualified gynecologists, obstetricians, oncologists, and other healthcare professionals. Dr. Benjamin Merlot, Consultant – Obstetrics and Gynecology and founding member of IFEM Endo, along with Dr. Sandesh Kade Specialist – Obstetrics and Gynecology, Dr. Monica Chauhan, Specialist – Obstetrics & Gynecology, and Dr. Jafaru Abu, Consultant Gynecological Oncology Surgery, all from Burjeel Medical City’s existing highly experienced team, are other members of the institute’s leadership team.
Advanced Surgical Care
The institute’s primary focus will be on advanced surgical procedures – in line with Burjeel Holdings focus on investing in complex and super-specialized capability in the UAE. It will operate state-of-the-art surgical suites equipped with the latest technology, allowing for advanced procedures such as laparoscopic and robotic surgeries. These minimally invasive procedures may enable shorter hospital stays, faster recovery times, and less scarring compared to traditional open surgeries. Gynecological cancers are another focus area at the institute, where, in addition to treating cancer, there is also an emphasis on preserving reproductive function in young patients, managing the side effects of treatment, and improving the quality of life for patients with advanced or recurrent gynecological malignancies. Additionally, the institute will offer highly advanced minimally invasive surgeries for endometriosis.
John Sunil, Burjeel Holdings CEO, said: “The launch of the Advanced Gynecology Institute showcases our commitment to excellence and cements our position as a leader in complex care. With a focus on advanced surgical procedures, specialized clinics, and personalized care, the institute is poised to make a significant impact on the healthcare sector and the health of women in the UAE and beyond.”
Professor Horace Roman added: “The launch of the institute is a significant milestone in women’s healthcare in the region. Women’s health needs are diverse and complex, requiring a holistic approach to ensure that each patient receives utmost care that meets her specific needs.
Dr. Sandesh Kade added: “We are committed to ensuring that each patient receives advanced care in a compassionate and supportive environment. We will work diligently to create a personalized treatment plan that achieves the best possible outcomes.”
The launch of the institute follows several recent milestones for Burjeel Holdings, including the launch of The Paley Middle East Clinic, the Kypros Nicolaides Fetal Medicine & Therapy Center and the pending commencement of operations in KSA, through its joint-venture with Leejam Sports. Through its JV with Leejam, Burjeel Holdings intends to open more than 60 dedicated sports medicine and rehabilitation clinics across KSA, with the first clinics scheduled to open in mid-2023.

About Burjeel Holdings
Founded in 2007, Burjeel Holdings is one of the leading private healthcare services providers in the MENA region. With a network of 62 assets, including 16 hospitals and 24 medical centers, as well as pharmacies and other allied services, the group provides the highest standard of patient care in the region. Burjeel Holdings’ brands include Burjeel Hospitals, Medeor Hospitals, LLH Hospitals, Lifecare Hospitals, and Tajmeel. It has 12 JCI-accredited facilities, with a total 1,660 patient beds across its operations in UAE and Oman, and holds a leading position in the UAE. The Group has comprehensive cancer care facilities in the UAE, and is the country’s leading mother and childcare provider.


M Unnikrishnan
Corporate Communications Officer
Burjeel Holdings
M: +971504275895 
Investor Relations:  
Chetan Sehgal 
Head of Investor Relations
Burjeel Holdings 
M: +971 56 682 0515